Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacokinetic Study of Pemetrexed in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

NCT00424242 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00424242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00424242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacokinetic Study of Pemetrexed in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2007
Completion date
September 30, 2011
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, chronic myeloproliferative disorders, leukemia, lymphoma, lymphoproliferative disorder, metastatic cancer, multiple myeloma and plasma cell neoplasm, myelodysplastic syndromes, precancerous condition, secondary myelofibrosis, unspecified adult solid tumor, protocol specific